Page last updated: 2024-11-03

rimantadine and Necrotizing Enterocolitis

rimantadine has been researched along with Necrotizing Enterocolitis in 1 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Research Excerpts

ExcerptRelevanceReference
"To review the maternal and neonatal outcomes after antepartum exposure to M2 ion channel inhibitors or oseltamivir to provide some guidance on the risk, if any, of antiviral medication during pregnancy."3.76Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. ( Greer, LG; McIntire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greer, LG1
Sheffield, JS1
Rogers, VL1
Roberts, SW1
McIntire, DD1
Wendel, GD1

Other Studies

1 other study available for rimantadine and Necrotizing Enterocolitis

ArticleYear
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:4

    Topics: Amantadine; Antiviral Agents; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Influenza

2010